Gentian Diagnostics ASA

Gentian Diagnostics ASAverified

GENT.OL

Price:

$57.4

Market Cap:

$885.24M

Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, and the United States. It offers in-vitro diagnostic reagents for clinical chemistry analyzers. The company's products include the gentian calprotectin immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Cystatin C, a superior GFR marker for the diagnosis and therapeutic control of renal function; NT-proBNP Immunoassay for diagnosis, monitoring, and assessment of severity in individuals suspected of having congestive heart failure; and Canine c-reactive protein (CR...[Read more]

Industry

Medical - Devices

IPO Date

2016-12-14

Stock Exchange

OSL

Ticker

GENT.OL

The Current Ratio as of December 2025 (TTM) for Gentian Diagnostics ASA (GENT.OL) is 5.98

According to Gentian Diagnostics ASA’s latest financial reports and current stock price. The company's current Current Ratio is 5.98. This represents a change of 4.46% compared to the average of 5.73 of the last 4 quarters.

Gentian Diagnostics ASA (GENT.OL) Historical Current Ratio (quarterly & annually)

How has GENT.OL Current Ratio performed in the past?

The mean historical Current Ratio of Gentian Diagnostics ASA over the last ten years is 11.43. The current 5.98 Current Ratio has changed 5.14% with respect to the historical average. Over the past ten years (40 quarters), GENT.OL's Current Ratio was at its highest in in the June 2018 quarter at 28.44. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

11.43

Median

10.33

Minimum

5.38

Maximum

20.53

Gentian Diagnostics ASA (GENT.OL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Gentian Diagnostics ASA Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.62%

Maximum Annual Current Ratio = 20.53

Minimum Annual Increase = -38.82%

Minimum Annual Current Ratio = 5.38

Quarterly (TTM)
Annual
YearCurrent RatioChange
20245.38-3.89%
20235.60-11.64%
20226.33-14.60%
20217.42-13.54%
20208.58-29.00%
201912.08-38.82%
201819.75-3.78%
201720.5365.96%
201612.37-23.73%
201516.221.62%

Gentian Diagnostics ASA (GENT.OL) Average Current Ratio

How has GENT.OL Current Ratio performed in the past?

The current Current Ratio of Gentian Diagnostics ASA (GENT.OL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.77

5-year avg

6.66

10-year avg

11.43

Gentian Diagnostics ASA (GENT.OL) Current Ratio vs. Peers

How is GENT.OL’s Current Ratio compared to its peers?

Gentian Diagnostics ASA’s Current Ratio is greater than Hofseth BioCare ASA (0.96), less than Nykode Therapeutics AS (170.98), greater than Navamedic ASA (1.49), greater than Lifecare AS (0.22), less than Lytix Biopharma AS (5.99), greater than ContextVision AB (publ) (4.95), less than Thor Medical ASA (8.87), greater than CodeLab Capital AS (-542.54), greater than Arctic Bioscience AS (0.83), greater than BerGenBio ASA (4.39),

Build a custom stock screener for Gentian Diagnostics ASA (GENT.OL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gentian Diagnostics ASA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gentian Diagnostics ASA (GENT.OL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gentian Diagnostics ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Gentian Diagnostics ASA's Current Ratio?

How is the Current Ratio calculated for Gentian Diagnostics ASA (GENT.OL)?

What is the highest Current Ratio for Gentian Diagnostics ASA (GENT.OL)?

What is the 3-year average Current Ratio for Gentian Diagnostics ASA (GENT.OL)?

What is the 5-year average Current Ratio for Gentian Diagnostics ASA (GENT.OL)?

How does the current Current Ratio for Gentian Diagnostics ASA (GENT.OL) compare to its historical average?